It was a landmark year for medical advancements in 2024, bringing a wave of innovative treatments that promise to reshape ...

A milestone review examining 1.4 million patients worldwide found that those who do not see the same doctor regularly are ...

The Shepherd’s Center of Greater Winston-Salem is offering a workshop for individuals turning 65 (as well as those who ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...

But that doesn't mean they have to come off the drugs. As with all pills, it's about weighing the pros and cons. Quite aside from the dementia worries, if a patient has been on the tablets for ...

Any use of antibiotics is not associated with incident dementia, cognitive impairment/no dementia, or accelerated cognitive decline.

Axovant has axed development of its key dementia drug intepirdine after results suggested it actually worsened symptoms compared with placebo. The news sent the neurology-focused Swiss biotech’s ...

Previous research has associated sleep medications with other health risks, such as falls, fractures, car accidents, and ...

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...